Enamine | Latest News & Updates - Jan 17, 2025 Release

Enamine has partnered with Schrödinger to provide ultra-large libraries of up to 6.5 billion compounds for virtual screening technologies...


Brought to you by RivalSense - an AI tool for monitoring any company.

RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡


Enamine

🌎 enamine.net

Enamine is a privately owned chemical company established in 1991, specializing in the synthesis of building blocks and small molecular weight compound libraries. The company supports pharmaceutical, biotech, and academic institutions with innovative chemistry solutions, offering services such as custom synthesis, compound library design, and lead optimization support. Enamine is recognized for having the world's largest reputable collection of chemical compounds tailored for the life sciences industry.


Enamine - Latest News and Updates

  • Enamine has partnered with Schrödinger to provide ultra-large libraries of up to 6.5 billion compounds for virtual screening technologies.
  • Enamine has established a set of ready-to-go image-based phenotypic assays for drug discovery.
  • Enamine chemists have developed a new cyclobutane molecule, EN300-1936715, available at new.enaminestore.com.
  • Enamine is expanding to Riga by opening a warehouse and subsidiary under the Bienta brand, creating up to 80 jobs for chemists and biologists.
  • Enamine's cover design for Organic Chemistry Frontiers has been shortlisted for the 2024 OCF Best Covers competition.
  • Enamine researchers, including Oleksandr Grygorenko, co-authored a paper on copper-mediated C–C coupling of alkenyl boronates and bromodifluoroacetates.
  • Enamine Ltd. co-funded a research project on machine learning for evaluating lipophilicity and acidity of fluorine-containing derivatives, published on January 13, 2025.
  • Oleksandr Grygorenko from Enamine announced a new publication in Advanced Synthesis & Catalysis featuring boron, fluorine, and radical chemistry.
  • Ivan Kondratov, Head of Medicinal Chemistry at Enamine, will present Enamine Building Blocks at Johannes Gutenberg University Mainz, Department of Chemistry.
  • Enamine is one of the top five key players in the global Chemical Building Block market, contributing to a combined market share of over 29%.

Sign up to receive regular updates


If you liked the insights, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.